RxDoctor Payments DataLook up a doctor →

Naz Wahab, MD

Family Medicine · Las Vegas, NVNPI 1285672816

Payments from drug & device makers

$735,304in general payments, 2019–2025

Across 271 payments — averaging $2713.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$578K
  • Mimedx Group, Inc.$69K
  • Royal Biologics, Inc.$42K
  • Kerecis Limited$30K
  • Aroa Biosurgery Incorporated$10K
  • ETS Wound Care LLC$2K
  • plus $5K from 25 others
$17,740in research payments, 2019–2025

Across 2 payments — averaging $8870.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mimedx Group, Inc.$12K
  • Reddress LTD$6K

What the payments were for

  • Consulting fees$14,9453%
  • Speaking & faculty fees$76,73814%
  • Travel & lodging$13,7522%
  • Food & beverage$9,5352%
  • Education$2,1780%
  • Other$446,15079%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$735,304 in reported general payments places this provider in the 95th percentile of 902 family medicine providers in Nevada.

See all family medicine providers in Nevada

Medicare billing

Part B allowed, 2024
$740,946
Medicare patients
200
Services billed
1,957

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate18$722
Mupirocin22$371
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$210

Paid to pharmacies, not to this prescriber.

Other family medicine in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →